NEW YORK — Clinical trials for rosacea lack diversity reflective of the U.S. census and disease rates, according to a poster presentation at the Skin of Color Update 2023 meeting.
“Rosacea is less frequently reported in individuals with skin of color,” Loren E. Hernandez, MD, of the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery at the University of Miami Miller School of Medicine, and colleagues wrote in their poster.
According to a 1993 to 2010 U.S. National Ambulatory Medical Care Survey on the racial and ethnic distribution of rosacea, 3.9% of patients